Russia To Approve Vaccine Access For Medical Personnel In Two Weeks, Rejects Safety Concerns
The Deciport Daily Quick-Look: 13 August 2020
Russia Vaccine Update: Russia plans to be able to produce 5 million doses a month by December-January.
Russia's approval of its vaccine has been met with concerns over its safety.
Security (Health) // BLUF: Russian officials have reportedly approved the new 'Sputnik-V' coronavirus vaccine for use on medical personnel in two weeks' time.
The vaccine was approved by Russia after less than two months testing, drawing global criticism over its safety; which has been shrugged off by Russian officials.
Russian President Vladimir Putin has claimed that his daughter had received the vaccine.
Russia plans to produce 5 million doses of the vaccine per month by December-January.
(See Point 3 Below for Further Information)
The Daily Quick-Look for 13 August 2020
The Deciport Daily Quick-Look is your at-a-glance look at several key events and situations around the world over the last 24 hours. Each headline contains the link to its source report.
BLUF = Bottom Line Up Front.
FYSA = For Your Situational Awareness.
1. ITALY - Security (Health, Travel): Italy orders coronavirus tests for arrivals from four countries
FYSA: Italy ruled on Wednesday that people travelling from Croatia, Greece, Malta and Spain must be tested for the coronavirus on arrival, as new infections increase in the four countries which are popular holiday destinations for Italians. Health Minister Roberto Speranza said on Facebook he had signed the new order, adding that anyone travelling from or through Colombia would not be allowed in Italy. “We have to continue with a prudent approach to defend the results we’ve achieved thanks to the sacrifice we have all made in recent months,” Speranza said. Italy was the first country outside China to be badly hit by the disease, and has recorded more than 35,000 deaths since its outbreak came to light on Feb. 21. The daily tally of new cases in Italy has accelerated over the last month, though less steeply than in numerous other European countries. Some 481 new infections were registered on Wednesday, and 10 deaths, the Civil Protection Agency reported. (Reuters. See link in heading for further reading)
2. TURKEY - Political, Security: Turkish police detain 25 in protest to support women's rights accord
FYSA: Turkish police on Wednesday detained 25 women protesting against the possibility of President Tayyip Erdogan’s AK Party pulling Turkey out of an international accord designed to protect women against domestic violence, a police source said. Reuters television video showed around a hundred protesters in the streets of the capital Ankara demanding better implementation of the Council of Europe’s Istanbul Convention. Scuffles broke out between police and protesters as security forces blocked the road and asked the women to disperse, the video showed. Despite signing the Istanbul Convention in 2011, Turkey had 474 femicides last year, double the number in 2011, according to a group which monitors murders of women. Many conservatives in Turkey say the pact, ironically forged in Istanbul, encourages violence by undermining family structures. Their opponents argue that the deal, and legislation approved in its wake, need to be implemented more stringently. The AK Party has been expected to announce a decision soon on whether to remain in the accord or withdraw. (Reuters. See link in heading for further reading)
3. RUSSIA - Security (Health): Russia Rejects Safety Concerns; Medics To Get Anti-Covid Shots In 2 Weeks
FYSA: Russia said on Wednesday the first batch of its Covid-19 vaccine would be ready for some medics within two weeks and rejected as "groundless" safety concerns aired by some experts over Moscow's rapid approval of the drug. President Vladimir Putin said on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine, after less than two months of human testing. The vaccine has not yet completed its final trials. Only about 10% of clinical trials are successful and some scientists fear Moscow may be putting national prestige before safety. "It seems our foreign colleagues are sensing the specific competitive advantages of the Russian drug and are trying to express opinions that in our opinion are completely groundless," Health Minister Mikhail Murashko said on Wednesday. He said the vaccine developed by Moscow's Gamaleya Institute would be administered to people, including doctors, on a voluntary basis, and would be ready soon. "The first packages of the medical vaccine against the coronavirus infection will be received within the next two weeks, primarily for doctors," he said. Alexander Gintsburg, director of the Gamaleya Institute, said clinical trials would be published once they have been assessed by Russia's own experts. He said Russia plans to be able to produce 5 million doses a month by December-January. (NDTV. See link in heading for further reading)
4. PAPUA NEW GUINEA - Security (Health): PNG announces record number of new Covid-19 cases
FYSA: Papua New Guinea has announced 55 confirmed cases of Covid-19 in the country, bringing the total to 287. The National Pandemic Response Control Centre said the 55 cases are the single highest recorded in a day, and include 18 from the National Capital District and 37 from Western Province. The 18 cases from the city's suburbs of Badili, Erima, Hohola, Tokarara, Kaugere, ATS, Sabama, Wanigela (Koki), June Valley and Boroko were recently tested at the Taurama Aquatic Drive through clinic and other urban clinics. The Western Province samples were tested in Brisbane through an arrangement by the Ok Tedi Mining Limited. (RNZ. See link in heading for further reading)
Sign up at the link below to get the Quick-Look straight to your inbox daily: https://bit.ly/2z15ztB For solutions to solve your Security and Intelligence problems, email us at email@example.com Take me to the Deciport Home Page The reporting period for this Daily Quick-Look is the previous 24 hours (unless stated otherwise). This Daily Quick-Look is comprised of reports from agencies around the world, and are referenced where possible. Deciport LLC is in no way associated with any agency listed. This Daily Quick-Look is for information purposes only. This Daily Quick-Look is not intended for planning purposes. The comments that comprise the 'Why It Matters' do not represent the opinions, viewpoints or assessment of the agency from which the linked source report originated, and is intended to add context for the reader as part of a summary.